Wendell Amy McBride, a director, bought Solventum Corp ($SOLV) shares once on the open market in the last year, totaling about $100 thousand, with the latest purchase on March 10, 2026. This ranks 2,204th among 4,983 individual insiders, below the average of $1.46 million per buyer across 3.29 transactions. McBride also sold Axogen Inc ($AXGN) shares four times for $1.32 million total, most recently on December 16, 2025, ranking 4,298th out of 11,678 sellers versus an average of $8.59 million over 6.37 trades.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 27, 2026 | Solventum Corp | $SOLV | Wendell Amy McBride | Director | M | Common Stock | 1980 | $0.00 | 7,019.0000 | 175,400,000 | 39.29% | 0.00% |
| March 27, 2026 | Solventum Corp | $SOLV | Wendell Amy McBride | Director | M | Restricted Stock Units | 1980 | $0.00 | 0.0000 | 175,400,000 | 100.00% | 0.00% |
| March 10, 2026 | Solventum Corp | $SOLV | Wendell Amy McBride | Director | P | Common Stock | 1475 | $68.03 | 5,039.0000 | 175,400,000 | 41.39% | 0.00% |
| Feb. 26, 2026 | HOLOGIC INC | $HOLX | Wendell Amy McBride | Director | A | Common Stock | 3190 | $0.00 | 25,784.0000 | 225,879,000 | 14.12% | 0.00% |
| Dec. 16, 2025 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | M | Common Stock | 20436 | $6.30 | 119,262.0000 | 49,088,436 | 20.68% | 0.04% |
| Dec. 16, 2025 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | S | Common Stock | 20436 | $29.31 | 112,074.0000 | 49,088,436 | 15.42% | 0.04% |
| Dec. 16, 2025 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | S | Common Stock | 5000 | $29.31 | 132,510.0000 | 49,088,436 | 3.64% | 0.01% |
| Dec. 16, 2025 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | M | Common Stock | 18248 | $7.04 | 137,510.0000 | 49,088,436 | 15.30% | 0.04% |
| Dec. 16, 2025 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | M | Common Stock | 5000 | $8.95 | 98,826.0000 | 49,088,436 | 5.33% | 0.01% |
| Dec. 16, 2025 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | M | Stock Option (right to purchase) | 18248 | $0.00 | 0.0000 | 49,088,436 | 100.00% | 0.04% |
| Dec. 16, 2025 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | M | Stock Option (right to purchase) | 20436 | $0.00 | 0.0000 | 49,088,436 | 100.00% | 0.04% |
| Dec. 16, 2025 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | M | Stock Option (right to purchase) | 5000 | $0.00 | 0.0000 | 49,088,436 | 100.00% | 0.01% |
| Dec. 16, 2025 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | S | Common Stock | 18248 | $29.31 | 93,826.0000 | 49,088,436 | 16.28% | 0.04% |
| June 19, 2025 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | A | Restricted Stock Units | 14150 | $0.00 | 14,150.0000 | 44,257,754 | 9999.99% | 0.03% |
| June 9, 2025 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | S | Common Stock | 4073 | $10.61 | 93,826.0000 | 44,257,754 | 4.16% | 0.01% |
| May 13, 2025 | Solventum Corp | $SOLV | Wendell Amy McBride | Director | M | Common Stock | 3564 | $0.00 | 3,564.0000 | 173,700,000 | 9999.99% | 0.00% |
| May 13, 2025 | Solventum Corp | $SOLV | Wendell Amy McBride | Director | M | Restricted Stock Units | 3564 | $0.00 | 0.0000 | 173,700,000 | 100.00% | 0.00% |
| May 6, 2025 | BAXTER INTERNATIONAL INC | $BAX | Wendell Amy McBride | Director | A | Common Stock, $1 par value | 7183 | $0.00 | 31,222.0000 | 683,000,000 | 29.88% | 0.00% |
| April 30, 2025 | Solventum Corp | $SOLV | Wendell Amy McBride | Director | A | Restricted Stock Units | 3403 | $0.00 | 3,403.0000 | 173,700,000 | 9999.99% | 0.00% |
| March 3, 2025 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | S | Common Stock | 5000 | $20.02 | 97,899.0000 | 44,257,754 | 4.86% | 0.01% |
| Feb. 26, 2025 | HOLOGIC INC | $HOLX | Wendell Amy McBride | Director | A | Non-qualified Stock Option (Right to Buy) | 5535 | $0.00 | 5,535.0000 | 232,107,000 | 9999.99% | 0.00% |
| Feb. 26, 2025 | HOLOGIC INC | $HOLX | Wendell Amy McBride | Director | A | Common Stock | 1864 | $0.00 | 22,594.0000 | 232,107,000 | 8.99% | 0.00% |
| Sept. 1, 2024 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | M | Common Stock | 11904 | $0.00 | 102,899.0000 | 42,878,543 | 13.08% | 0.03% |
| Sept. 1, 2024 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | M | Restricted Stock Units | 11904 | $0.00 | 0.0000 | 42,878,543 | 100.00% | 0.03% |
| June 6, 2024 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | A | Common Stock | 10653 | $0.00 | 90,995.0000 | 42,878,543 | 13.26% | 0.02% |
| June 6, 2024 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | A | Stock Option (right to purchase) | 18248 | $0.00 | 18,248.0000 | 42,878,543 | 9999.99% | 0.04% |
| May 13, 2024 | Solventum Corp | $SOLV | Wendell Amy McBride | Director | A | Restricted Stock Units | 3564 | $0.00 | 3,564.0000 | 172,700,000 | 9999.99% | 0.00% |
| May 13, 2024 | Solventum Corp | $SOLV | Wendell Amy McBride | Director | A | Restricted Stock Units | 1980 | $0.00 | 5,544.0000 | 172,700,000 | 55.56% | 0.00% |
| May 7, 2024 | BAXTER INTERNATIONAL INC | $BAX | Wendell Amy McBride | Director | A | Common Stock, $1 par value | 5952 | $0.00 | 23,876.0000 | 683,000,000 | 33.21% | 0.00% |
| March 7, 2024 | HOLOGIC INC | $HOLX | Wendell Amy McBride | Director | A | Non-qualified Stock Option (Right to Buy) | 4536 | $0.00 | 4,536.0000 | 248,831,000 | 9999.99% | 0.00% |
| March 7, 2024 | HOLOGIC INC | $HOLX | Wendell Amy McBride | Director | A | Common Stock | 1572 | $0.00 | 20,730.0000 | 248,831,000 | 8.21% | 0.00% |
| Sept. 6, 2023 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | P | Common Stock | 10000 | $6.22 | 80,342.0000 | 42,083,125 | 14.22% | 0.02% |
| Sept. 1, 2023 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | A | Stock Option (right to purchase) | 20436 | $0.00 | 20,436.0000 | 42,083,125 | 9999.99% | 0.05% |
| Sept. 1, 2023 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | A | Restricted Stock Units | 11904 | $0.00 | 11,904.0000 | 42,083,125 | 9999.99% | 0.03% |
| June 1, 2023 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | M | Common Stock | 6459 | $0.00 | 70,342.0000 | 42,083,125 | 10.11% | 0.02% |
| June 1, 2023 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | M | Restricted Stock Units | 6459 | $0.00 | 0.0000 | 42,083,125 | 100.00% | 0.02% |
| May 12, 2023 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | M | Stock Option (right to buy) | 25000 | $0.00 | 0.0000 | 42,083,125 | 100.00% | 0.06% |
| May 12, 2023 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | M | Common Stock | 25000 | $9.22 | 60,133.0000 | 42,083,125 | 71.16% | 0.06% |
| May 12, 2023 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | M | Common Stock | 3750 | $9.22 | 63,883.0000 | 42,083,125 | 6.24% | 0.01% |
| May 12, 2023 | Axogen, Inc. | $AXGN | Wendell Amy McBride | Director | M | Stock Option (right to buy) | 3750 | $0.00 | 0.0000 | 42,083,125 | 100.00% | 0.01% |
| May 2, 2023 | BAXTER INTERNATIONAL INC | $BAX | Wendell Amy McBride | Director | A | Common Stock, $1 par value | 4573 | $0.00 | 17,894.0000 | 683,000,000 | 34.33% | 0.00% |
| March 9, 2023 | HOLOGIC INC | $HOLX | Wendell Amy McBride | Director | A | Non-qualified Stock Option (Right to Buy) | 4210 | $0.00 | 4,210.0000 | 0 | 9999.99% | 0.00% |
| March 9, 2023 | HOLOGIC INC | $HOLX | Wendell Amy McBride | Director | A | Common Stock | 1465 | $0.00 | 19,158.0000 | 0 | 8.28% | 0.00% |